Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-06-30 | New | $12,999,997 | $12,999,997 | Equity Only | 06b | SEC link |
2022-11-18 | New | $24,304,480 | $24,304,480 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
Jeffrey W. Bird | Director |
Kim Kamdar | Director |
Keith Loebner | Director |
Michael L. Speiser | Director |
Robert Spitale | Director, Executive |